Stock Events

Stock Events

Currenc Group 

$3.17
19
-$0.1-3.06% Today

Statistics

Day High
3.39
Day Low
3.17
52W High
4.49
52W Low
0.36
Volume
213,151
Avg. Volume
-
Mkt Cap
241.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27MayExpected
Q2 2022
Q3 2022
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.13
-0.07
-0.01
0.05
Expected EPS
N/A
Actual EPS
N/A

Financials

-85.01%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
92.87MRevenue
-78.95MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CURR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap166.82B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in similar therapeutic areas as Avenir, making them direct competitors in the healthcare market.
AMGEN
AMGN
Mkt Cap183.12B
Amgen is a biotech firm focusing on novel therapies, including treatments for conditions that Avenir Wellness Solutions also targets.
Pfizer
PFE
Mkt Cap147.62B
Pfizer is a large pharmaceutical company with a diverse product portfolio that includes medications in direct competition with those of Avenir Wellness Solutions.
Merck
MRK
Mkt Cap302.33B
Merck operates globally in pharmaceuticals, including areas like immunotherapy and oncology, competing with Avenir's product lines.
Abbvie
ABBV
Mkt Cap381.1B
AbbVie offers a range of biopharmaceuticals that directly compete with Avenir Wellness Solutions in multiple therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap121.42B
Bristol-Myers Squibb, with its broad range of pharmaceutical products, competes in the same market segments as Avenir Wellness Solutions.
Lilly(Eli) &
LLY
Mkt Cap949.7B
Eli Lilly and Company produces medicines in areas such as mental health and diabetes, overlapping with Avenir's market interests.
Novartis
NVS
Mkt Cap290.05B
Novartis is a global healthcare company that produces drugs that directly compete with Avenir Wellness Solutions' offerings.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson has a large portfolio of pharmaceuticals that includes competitive products in the wellness and therapeutic sectors targeted by Avenir.
Regeneron Pharmaceuticals
REGN
Mkt Cap66.98B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in areas like immunology and oncology, which are key focus areas for Avenir Wellness Solutions.

About

Currenc Group, Inc. engages in operating a fintech banking platform. It operates through the following segments: Remittance Services, Sales of Airtime, and Other Services. The company is headquartered in Singapore.
Show more...
CEO
Mr. King Ong Kong
Employees
2
Country
Cayman Islands
ISIN
KYG478621009

Listings

OTC Link
US
AVRW
XNAS
US
CURR
BOATS
BOATS
CURR.BOATS

0 Comments

Share your thoughts

FAQ

What is Currenc Group stock price today?▼
The current price of CURR is $3.17 USD — it has decreased by -3.06% in the past 24 hours. Watch Currenc Group stock price performance more closely on the chart.
What is Currenc Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Currenc Group stocks are traded under the ticker CURR.
Is Currenc Group stock price growing?▼
CURR stock has fallen by -1.09% compared to the previous week, the month change is a -3.79% fall, over the last year Currenc Group has showed a +551.42% increase.
What is Currenc Group market cap?▼
Today Currenc Group has the market capitalization of 241.19M
What is Currenc Group revenue for the last year?▼
Currenc Group revenue for the last year amounts to 92.87M USD.
What is Currenc Group net income for the last year?▼
CURR net income for the last year is -78.95M USD.
How many employees does Currenc Group have?▼
As of May 27, 2026, the company has 2 employees.
In which sector is Currenc Group located?▼
Currenc Group operates in the Finance & Payments sector.
When did Currenc Group complete a stock split?▼
The last stock split for Currenc Group was on July 21, 2016 with a ratio of 3.6:1.
Where is Currenc Group headquartered?▼
Currenc Group is headquartered in Singapore, Cayman Islands.